Your browser doesn't support javascript.
loading
CD56bright natural killer regulatory cells in filgrastim primed donor blood or marrow products regulate chronic graft-versus-host disease: the Canadian Blood and Marrow Transplant Group randomized 0601 study results.
Kariminia, Amina; Ivison, Sabine; Ng, Bernard; Rozmus, Jacob; Sung, Susanna; Varshney, Avani; Aljurf, Mahmoud; Lachance, Sylvie; Walker, Irwin; Toze, Cindy; Lipton, Jeff; Lee, Stephanie J; Szer, Jeff; Doocey, Richard; Lewis, Ian; Smith, Clayton; Chaudhri, Naeem; Levings, Megan K; Broady, Raewyn; Devins, Gerald; Szwajcer, David; Foley, Ronan; Mostafavi, Sara; Pavletic, Steven; Wall, Donna A; Couban, Stephan; Panzarella, Tony; Schultz, Kirk R.
Afiliação
  • Kariminia A; Michael Cuccione Childhood Cancer research Program, BC Children's Hospital, Department of Pediatrics, University of British Columbia, Vancouver, BC, Canada.
  • Ivison S; Michael Cuccione Childhood Cancer research Program, BC Children's Hospital, Department of Pediatrics, University of British Columbia, Vancouver, BC, Canada.
  • Ng B; Department of Statistics, University of British Columbia, Centre for Molecular Medicine and Therapeutics, Vancouver, BC, Canada.
  • Rozmus J; Michael Cuccione Childhood Cancer research Program, BC Children's Hospital, Department of Pediatrics, University of British Columbia, Vancouver, BC, Canada.
  • Sung S; Michael Cuccione Childhood Cancer research Program, BC Children's Hospital, Department of Pediatrics, University of British Columbia, Vancouver, BC, Canada.
  • Varshney A; Michael Cuccione Childhood Cancer research Program, BC Children's Hospital, Department of Pediatrics, University of British Columbia, Vancouver, BC, Canada.
  • Aljurf M; King Faisal Specialist Hospital and Research Center, Riyadh, Kingdom of Saudi Arabia.
  • Lachance S; Hôpital Maisonneuve-Rosemont, Université de Montréal, QC, Canada.
  • Walker I; Hamilton Health Sciences Centre and McMaster University, Hamilton, ON, Canada.
  • Toze C; Leukemia/Bone Marrow Transplant Program of BC, Vancouver General Hospital, British Columbia Cancer Agency and the University of British Columbia, Vancouver, BC, Canada.
  • Lipton J; Princess Margaret Cancer Centre University of Toronto, ON, Canada.
  • Lee SJ; Fred Hutchinson Cancer Research Centre, Seattle, WA, USA.
  • Szer J; Royal Melbourne Hospital and University of Melbourne, Australia.
  • Doocey R; Auckland City and Starship Children's Hospital, Auckland, New Zealand.
  • Lewis I; Institute of Medical and Veterinary Sciences, Adelaide, Australia.
  • Smith C; General Hematology, Blood Cancers and Bone Marrow Transplant Program, University of Colorado Hospital, Aurora, CO, USA.
  • Chaudhri N; King Faisal Specialist Hospital and Research Center, Riyadh, Kingdom of Saudi Arabia.
  • Levings MK; BC Children's Hospital Research Institute and Department of Surgery, University of British Columbia, Vancouver, BC, Canada.
  • Broady R; Leukemia/Bone Marrow Transplant Program of BC, Vancouver General Hospital, British Columbia Cancer Agency and the University of British Columbia, Vancouver, BC, Canada.
  • Devins G; Princess Margaret Cancer Centre University of Toronto, ON, Canada.
  • Szwajcer D; CancerCare Manitoba, Winnipeg, MB, Canada.
  • Foley R; Hamilton Health Sciences Centre and McMaster University, Hamilton, ON, Canada.
  • Mostafavi S; Department of Statistics, University of British Columbia, Centre for Molecular Medicine and Therapeutics, Vancouver, BC, Canada.
  • Pavletic S; Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.
  • Wall DA; The Hospital for Sick Children and University of Toronto, ON, Canada.
  • Couban S; Nova Scotia Health Authority and Dalhousie University, Halifax, NS, Canada.
  • Panzarella T; Princess Margaret Cancer Centre University of Toronto, ON, Canada.
  • Schultz KR; Michael Cuccione Childhood Cancer research Program, BC Children's Hospital, Department of Pediatrics, University of British Columbia, Vancouver, BC, Canada kschultz@mail.ubc.ca.
Haematologica ; 102(11): 1936-1946, 2017 11.
Article em En | MEDLINE | ID: mdl-28935847
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Células Matadoras Naturais / Transplante de Células-Tronco Hematopoéticas / Antígeno CD56 / Mobilização de Células-Tronco Hematopoéticas / Filgrastim / Doença Enxerto-Hospedeiro Tipo de estudo: Clinical_trials / Diagnostic_studies / Prognostic_studies Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Haematologica Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Canadá
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Células Matadoras Naturais / Transplante de Células-Tronco Hematopoéticas / Antígeno CD56 / Mobilização de Células-Tronco Hematopoéticas / Filgrastim / Doença Enxerto-Hospedeiro Tipo de estudo: Clinical_trials / Diagnostic_studies / Prognostic_studies Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Haematologica Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Canadá